Latest Articles

Publication Date
Portugal introduces paid menstrual leave for endometriosis and adenomyosis - Lockton

Portugal introduces paid menstrual leave for endometriosis and adenomyosis Lockton

Published: May 15, 2025, 4:09 p.m.
Singer RuthAnne Cunningham shares her endometriosis and adenomyosis diagnoses - MSN

Singer RuthAnne Cunningham shares her endometriosis and adenomyosis diagnoses MSN

Published: April 28, 2025, 12:21 a.m.
Singer RuthAnne Cunningham shares her endometriosis and adenomyosis diagnoses - RSVP Live

Singer RuthAnne Cunningham shares her endometriosis and adenomyosis diagnoses RSVP Live

Published: April 27, 2025, 3:28 p.m.
Adenomyosis affects as many women as endometriosis, so why is it virtually unknown? - Glamour UK

Adenomyosis affects as many women as endometriosis, so why is it virtually unknown? Glamour UK

Published: April 20, 2025, 10 a.m.
Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis - BMC Women's Health

Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis BMC Women's Health

Published: April 3, 2025, 6:05 p.m.
'Ovariostasis' as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age.

Ovariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case …

Published: April 3, 2025, midnight
Artificial intelligence applications in endometriosis imaging.

Artificial intelligence (AI) may have the potential to improve existing diagnostic challenges in endometriosis imaging. To better direct future research, this descriptive review summarizes the general landscape of AI applications …

Published: April 1, 2025, midnight
Reduced live birth rates following ART in adenomyosis patients: a matched control study.

How does adenomyosis affect live birth rates (LBRs) in women undergoing ART compared to a matched control population?

Published: March 30, 2025, midnight
Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial.

This study evaluated the effectiveness of quinagolide vaginal ring on reducing total lesion size in endometrioma, deep infiltrating endometriosis (DIE), and adenomyosis, as assessed using high-resolution MRI and imaging biomarkers.

Published: March 30, 2025, midnight
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series - BioMed Central

Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series BioMed Central

Published: March 29, 2025, 11:38 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!